Castelein Caley's Form 4 filing
Tourmaline Bio, Inc. (TRML) · filed Oct 27, 2023
- Accession no.
- 0001209191-23-053791
- Filed
- Oct 27, 2023
- Trade date
- Oct 25-27, 2023
- Filing delay
- 2 days
- Rule 10b5-1 plan
- Not checked
This filing lists 2 non-derivative transactions and 0 derivative transactions. Open-market purchases total $280.6K. It was filed 2 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Castelein CaleyCIK 0001355758 | Director |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Oct 25, 2023 | Common Stock | PPurchaseAcquired | +4,200 | $12.07 | +$50,694 | 500,719 | Direct | |
| Oct 27, 2023 | Common Stock | PPurchaseAcquired | +15,800 | $14.55 | +$229,890 | 516,519 | Direct |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.